Category: Diabetes
Oceania Diabetes
-
Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Industry Forecast till 2032
... CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced ... Read More
-
Asia Pacific Blood Glucose Monitoring Market Research Report Information, By Product Type (Invasive Glucose Monitoring, Flash Glucose Monitoring, and CGM), By Application (Type 1 Diabetes, and Type 2 Diabetes), By End-User (Diagnostics Center, Hospitals, and Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032
... Clinics), And, By Region (Asia-Pacific) –Industry Forecast till 2032 The Asia Pacific Blood Glucose Monitoring Market was valued at USD 1.1 billion in 2022. The Asia Pacific Blood Glucose Monitoring market is expected to increase ... Read More
-
Elderly Care Services Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Type (Pharmaceuticals, Housing & Assistive Devices); By Service Type (Adult Day Care, Institutional Care, Home Care); By Service Provider (Private, Public); By Application (Respiratory Diseases, Diabetes, Osteoporosis, Heart Diseases, Neurological Diseases, Kidney Diseases, Arthritis, Cancer); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA))
... Provider (Private, Public); By Application (Respiratory Diseases, Diabetes, Osteoporosis, Heart Diseases, Neurological Diseases, Kidney Diseases, Arthritis, Cancer); By Region (North America, Europe, Asia Pacific (APAC), Latin America (LATAM), Middle East and Africa (MEA)) Global Elderly ... Read More
-
Insulin Pens Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global insulin pens market is poised for substantial growth, fueled by the rising prevalence of diabetes and continuous advancements in insulin delivery technology. Projections indicate a compound annual growth rate (CAGR) of 7.8%, with the ... Read More
-
Asia-Pacific Omega-3 Supplements Market, By Source (Fish Oil, Krill Oil, Algae Oil, Others), By Form (Tablets, Capsules, Soft Gels, Others), By Functionality (Cardiovascular Health, Brain, Nervous System & Mental Health, Eye Diseases, Diabetes, Others), By End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of APAC), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... End User (Adults, Geriatric, Pregnant Women, Children, Infants), By Distribution Channel (Supermarkets/ Hypermarkets/Food Stores, Drug Stores & Pharmacies, Online Retailers, Others), By Country (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, ... Read More
-
Australia And New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029
... 2024, and is expected to reach USD 1.30 billion by 2029, growing at a CAGR of 2.70% during the forecast period (2024-2029). Key Highlights A holistic study of the market studied has been carried out ... Read More
-
New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 552.60 million by 2029, growing at a CAGR of 1.10% during the forecast period (2024-2029). After COVID-19 was detected, the risk of developing type 1 diabetes increased. The ... Read More
-
New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... is expected to reach USD 367.23 million by 2029, growing at a CAGR of 2.60% during the forecast period (2024-2029). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients ... Read More
-
New Zealand Diabetes Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 512.09 million by 2029, growing at a CAGR of 3.30% during the forecast period (2024-2029). An individual's risk of infection, including other viral infections like the flu, is increased by diabetes. If ... Read More
-
New Zealand Diabetes Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... to reach USD 872.63 million by 2029, growing at a CAGR of 4% during the forecast period (2024-2029). Type 1 diabetes was more likely to occur after being diagnosed with COVID-19. Young pediatric patients and ... Read More
-
Asia Pacific Endothelial Dysfunction Market Forecast to 2028 - Regional Analysis - by Cause (Hypertension, Diabetes, Hypercholestrolaemia, Bechet's Disease, Obesity, and Others), Test Type [Invasive Tests and Non-Invasive Tests (Flow Mediated Dilatory, Peripheral Arterial Tonometry (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others)
... (PAT), Venous Occlusion Pletismography, Circulating Markers, and Others)], and End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics, and Others) The Asia Pacific endothelial dysfunction market is expected to grow from US$ 304.48 million in 2022 ... Read More
-
Asia Pacific Bioanalytical Testing Services Market Forecast to 2030 - Regional Analysis - by Services (Pharmacokinetics, Biomarkers, Immunogenicity, Virology Testing, Cell-based assays, and Others); Disease Indication (Cardiovascular, Neurological Disorders, Metabolic Disorders, Autoimmune Disorders, Respiratory Diseases, Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others]
... Oncology, Sexual Health, Bone Disease, and Others); and End User [Pharmaceutical and Biopharmaceutical Companies, Contract Research Organization (CRO), Contract Development And Manufacturing Organization (CDMO), and Others] The Asia Pacific bioanalytical testing services market was valued ... Read More
-
Asia Pacific Diabetic Foot Ulcer Market Forecast to 2030 - Regional Analysis -By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Moderate, Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care)
... Mild, and Severe), and End User (Hospitals, Ambulatory Surgery Centers, and Home Care) The Asia Pacific diabetic foot ulcer market was valued at US$ 1,455.82 million in 2022 and is expected to reach US$ 2,472.61 ... Read More
-
Asia Pacific Fundus Cameras Market Forecast to 2030 - Regional Analysis - by Type (Mydriatic Fundus Camera, Non-Mydriatic Fundus Camera, Hybrid Fundus Camera, and ROP Fundus Camera), Portability (Handheld and Tabletop), Application (Diabetic Retinopathy, Age-Related Macular Degeneration, Retinal Vascular Disorders, and Others), and End User (Hospitals, Ophthalmology Centers, and Others)
... Macular Degeneration, Retinal Vascular Disorders, and Others), and End User (Hospitals, Ophthalmology Centers, and Others) The Asia Pacific fundus cameras market was valued at US$ 171.61 million in 2022 and is expected to reach US$ ... Read More
-
Insulin Delivery Device Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Key Factors Driving Market Growth Include Rising Obesity and Diabetes Rates, Technological Advancements, and Increased Patient Awareness The global insulin delivery devices market, crucial for the treatment of diabetes, is witnessing remarkable growth during forecast ... Read More
-
Asia Pacific Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)
... and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare) The Asia Pacific glucose monitoring devices market is expected to grow from US$ 3,386.90 million in 2022 to US$ 8,471.46 million by 2030. It ... Read More
-
Australia In Vitro Diagnostics Market Assessment By Product Type [Instruments, Reagents & Consumables, Data Management Software], By Techniques [Immunodiagnostics, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Haemostasias, Urinalysis, Others], By Settings [Laboratories, Point-of-Care], By Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F
... Application [Ophthalmology, Infectious Diseases, Diabetes, Drug Testing/ Pharmacogenomics, Autoimmune Diseases, Cardiology, Oncology, HIV/AIDS, Nephrology, Gastroenterology, Others], By End-user [Clinical Laboratories, Hospitals, Point-of-care testing centers, Others], By Region, Opportunities and Forecast, 2016-2030F Australia in vitro diagnostics ... Read More
-
Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User (Physician Offices and Clinics, Urgent Care Centers, and Ambulatory Care Centers), By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) POCT enables quick and accurate diagnostic testing with ... Read More
-
Allogeneic Stem Cell Transplantation Market, By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Dental Pulp, Others), By Application (Cancer, Autoimmune Diseases, Blood Disorders, Cardiac Disorders, Neurological Disorders, Diabetes, Others), By End User (Hospitals, Research Institutes, Specialty Clinics, Others), By Cell Type (Allogeneic MSCs, Allogeneic HSCs, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... (Hospitals, Research Institutes, Specialty Clinics, Others), By Cell Type (Allogeneic MSCs, Allogeneic HSCs, Others), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific) Allogeneic stem cell transplantation is a medical ... Read More
-
Australia & South Korea Diabetic Foot Ulcer Market Size and Forecasts (2020 - 2030), Country Share, Trends, and Growth Opportunity Analysis Coverage By: Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, and Neuro-Ischemic Ulcers), Treatment Type (Advanced Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country
... Wound Care Dressings, Biologics, and Therapy Device), Infection Severity (Mild, Moderate, and Severe), End User (Hospitals, Ambulatory Surgery Centers, and Home Care), and Country The Australia & South Korea diabetic foot ulcer market is projected ... Read More
-
Australia Diabetes Care Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 776 million by 2028, growing at a CAGR of 2.46% during the forecast period (2023-2028). The COVID-19 pandemic positively impacted the Australia Diabetes Care Devices Market growth. Patients with diabetes, infected with ... Read More
-
Australia And New Zealand Diabetes Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... billion in 2023 to USD 1.27 billion by 2028, at a CAGR of 2.70% during the forecast period (2023-2028). Key Highlights A holistic study of the market studied has been carried out by incorporating various ... Read More
-
Australia Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... to reach USD 939.07 million by 2028, growing at a CAGR of 3.60% during the forecast period (2023-2028). The COVID-19 epidemic boosted the expansion of the Australia Diabetes Care Drugs Market. Diabetes patients infected with ... Read More
-
Asia-Pacific Insulin Delivery Devices Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... USD 20.99 billion by 2028, at a CAGR of 2.68% during the forecast period (2023-2028). The Asia-Pacific region has witnessed an astounding increase in the prevalence of diabetes in patients, in recent years. The increasing ... Read More
-
New Zealand Oral Anti-Diabetic Drug Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)
... 2023 to USD 357.92 million by 2028, at a CAGR of 2.60% during the forecast period (2023-2028). The likelihood of having type 1 diabetes increased when COVID-19 was discovered. Young pediatric patients and older adult ... Read More
Research Assistance
